We are live on ! Find out more
CCM

Coldstream Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 17.95%
This Fund
S&P 500
This Quarter Est. Return
-1.83%
1 Year Est. Return
+17.95%
3 Year Est. Return
+59.03%
5 Year Est. Return
10 Year Est. Return
AUM
$4.7B
AUM Growth
+$4.46M
Cap. Flow
+$147M
Cap. Flow %
3.12%
Top 10 Hldgs %
39.64%
Holding
3,543
New
2,477
Increased
543
Reduced
471
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 12.69%
2 Financials 5.41%
3 Consumer Discretionary 4.72%
4 Healthcare 4.05%
5 Industrials 3.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMA
3276
ImageneBio Inc
IMA
$64.9M
$672 ﹤0.01%
+44
New +$759
KGS icon
3277
Kodiak Gas Services
KGS
$6.01B
$672 ﹤0.01%
+18
New +$767
QURE icon
3278
uniQure
QURE
$3.03B
$668 ﹤0.01%
+63
New +$883
FLOC
3279
Flowco Holdings
FLOC
$852M
$667 ﹤0.01%
+26
New +$686
KVYO icon
3280
Klaviyo
KVYO
$5.72B
$666 ﹤0.01%
+22
New +$887
ABSI icon
3281
Absci
ABSI
$1.44B
$665 ﹤0.01%
+265
New +$972
TRML
3282
DELISTED
Tourmaline Bio
TRML
$655 ﹤0.01%
+43
New +$689
TREE icon
3283
LendingTree
TREE
$474M
$654 ﹤0.01%
+13
New +$579
XPOF icon
3284
Xponential Fitness
XPOF
$280M
$650 ﹤0.01%
+78
New +$1.09K
ADCT icon
3285
ADC Therapeutics
ADCT
$140M
$642 ﹤0.01%
+455
New +$773
IIIV icon
3286
i3 Verticals
IIIV
$427M
$642 ﹤0.01%
+26
New +$659
LXRX icon
3287
Lexicon Pharmaceuticals
LXRX
$1.11B
$640 ﹤0.01%
+1,388
New +$876
MGNX icon
3288
MacroGenics
MGNX
$248M
$639 ﹤0.01%
+503
New +$1.31K
SABA
3289
Saba Capital Income & Opportunities Fund II
SABA
$223M
$636 ﹤0.01%
+73
New +$658
PRTA icon
3290
Prothena Corp
PRTA
$444M
$632 ﹤0.01%
+51
New +$721
BCAL icon
3291
Southern California Bancorp
BCAL
$693M
$631 ﹤0.01%
+44
New +$683
LYEL icon
3292
Lyell Immunopharma
LYEL
$333M
$628 ﹤0.01%
+58
New +$711
ALCO icon
3293
Alico
ALCO
$283M
$627 ﹤0.01%
+21
New +$624
AMR icon
3294
Alpha Metallurgical Resources
AMR
$1.78B
$627 ﹤0.01%
+5
New +$814
SGHT icon
3295
Sight Sciences
SGHT
$307M
$624 ﹤0.01%
+260
New +$732
EVGO icon
3296
EVgo
EVGO
$244M
$623 ﹤0.01%
+234
New +$725
RAPT
3297
DELISTED
RAPT Therapeutics
RAPT
$617 ﹤0.01%
+63
New +$619
TARS icon
3298
Tarsus Pharmaceuticals
TARS
$2.67B
$616 ﹤0.01%
+12
New +$593
JGH icon
3299
Nuveen Global High Income Fund
JGH
$354M
$615 ﹤0.01%
+47
New +$617
USCB icon
3300
USCB Financial Holdings
USCB
$416M
$613 ﹤0.01%
+33
New +$615

Similar funds

Coldstream Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Coldstream Capital Management held 3,543 positions worth $4.7B, up 0.1% from $4.69B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Coldstream Capital Management deployed $147M of net new capital in Q1 2025, opening 2,477 new positions and adding to 543 existing holdings. Its largest new stake was iShares 3-7 Year Treasury Bond ETF: 71,368 shares worth $8.43M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $139M trimmed.

  • Coldstream Capital Management's largest Q1 2025 buy was iShares 3-7 Year Treasury Bond ETF: 71,368 shares worth $8.43M.
  • Coldstream Capital Management added most to iShares Russell 1000 ETF in Q1 2025, an estimated $48.2M increase.
  • Coldstream Capital Management's biggest Q1 2025 reduction was Microsoft, cutting an estimated $139M.
  • Coldstream Capital Management fully exited Innovator US Equity Power Buffer ETF June in Q1 2025, selling an estimated $345K.
  • Coldstream Capital Management's ten largest holdings make up 40% of its $4.7B portfolio in Q1 2025.
  • Coldstream Capital Management opened 2,477 new positions and closed 3 in Q1 2025.
  • Coldstream Capital Management's portfolio value rose 0.1% quarter-over-quarter to $4.7B.

Based on Coldstream Capital Management's 13F filing for Q1 2025, filed 13 May 2025.